Gass M, Larson J, Cochrane B, Manson JE, Lane D, Barnabei V, Ockene J, Stefanick ML, Mouton C. Sexual activity and vaginal symptoms in the postintervention phase of the Womenes Health Initiative Hormone Therapy Trials. Menopause. 2018; 25(3).
Frederick PJ, Szender JB, Hussein AA, Kesterson JP, Shelton JA, Anderson TL, Barnabei VM, Guru K. Surgical Competency for Robot-Assisted Hysterectomy: Development and Validation of a Robotic Hysterectomy Assessment Score (RHAS). J Minim Invasive Gynecol. 2017; 24(1).
Smith CJ, Ryckman KK, Barnabei VM, Howard BV, Isasi CR, Sarto GE, Tom SE, Van Horn LV, Wallace RB, Robinson JG. The impact of birth weight on cardiovascular disease risk in the Women's Health Initiative. Nutr Metab Cardiovasc Dis. 2016; 26(3).
Echebiri NC, McDoom MM, Aalto MM, Fauntleroy J, Nagappan N, Barnabei VM. Prophylactic use of negative pressure wound therapy after cesarean delivery. Obstet Gynecol. 2015; 125(2).
Pal L, Hailpern SM, Santoro NF, Freeman R, Barad D, Kipersztok S, Barnabei VM, Wassertheil-Smoller S. Increased incident hip fractures in postmenopausal women with moderate to severe pelvic organ prolapse. Menopause. 2011; 18(9).
Brunner RL, Aragaki A, Barnabei V, Cochrane BB, Gass M, Hendrix S, Lane D, Ockene J, Woods NF, Yasmeen S, Stefanick M, Barnabei VM. Menopausal symptom experience before and after stopping estrogen therapy in the Women's Health Initiative randomized, placebo-controlled trial. Menopause. 2010; 17(5).
Barnabei VM, O'Connor JJ, Nimphius NM, Vierkant RA, Eaker ED. The effects of a web-based tool on patient-provider communication and satisfaction with hormone therapy: a randomized evaluation. J Womens Health (Larchmt). 2008; 17(1).
Pal L, Hailpern SM, Santoro NF, Freeman R, Barad D, Kipersztok S, Barnabei VM, Wassertheil-Smoller S. Association of pelvic organ prolapse and fractures in postmenopausal women: analysis of baseline data from the Women's Health Initiative Estrogen Plus Progestin trial. Menopause. 2008; 15(1).
Rossouw JE, Prentice RL, Manson JE, Wu L, Barad D, Barnabei VM, Ko M, LaCroix AZ, Margolis KL, Stefanick ML. Postmenopausal hormone therapy and risk of cardiovascular disease by age and years since menopause. JAMA. 2007; 297(13).
Curb JD, Prentice RL, Bray PF, Langer RD, Van Horn L, Barnabei VM, Bloch MJ, Cyr MG, Gass M, Lepine L, Rodabough RJ, Sidney S, Uwaifo GI, Rosendaal FR. Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch Intern Med. 2006; 166(7).
Ockene JK, Barad DH, Cochrane BB, Larson JC, Gass M, Wassertheil-Smoller S, Manson JE, Barnabei VM, Lane DS, Brzyski RG, Rosal MC, Wylie-Rosett J, Hays J. Symptom experience after discontinuing use of estrogen plus progestin. JAMA. 2005; 294(2).
Hendrix SL, Cochrane BB, Nygaard IE, Handa VL, Barnabei VM, Iglesia C, Aragaki A, Naughton MJ, Wallace RB, McNeeley SG. Effects of estrogen with and without progestin on urinary incontinence. JAMA. 2005; 293(8).
Autry AM, Simpson DE, Bragg DS, Meurer LN, Barnabei VM, Green SS, Bertling C, Fisher B. Personal digital assistant for "real time" assessment of women's health in the clinical years. Am J Obstet Gynecol. 2002; 187(3 Sup).
Autry AM, Meurer LN, Barnabei VM, Green SS, Johnson-Masotti AP, Otto-Salaj LL, Bragg DS, Treat R, Simpson DE. A longitudinal women's health curriculum: a multi-method, multiperspective needs assessment. Am J Obstet Gynecol. 2002; 187(3 Sup).
Hendrix SL, Clark A, Nygaard I, Aragaki A, Barnabei V, McTiernan A, Barnabei VM. Pelvic organ prolapse in the Women's Health Initiative: gravity and gravidity. Am J Obstet Gynecol. 2002; 186(6).
Loncar J, Barnabei VM, Larsen JW. Advent of maternal serum markers for Down syndrome screening. Obstet Gynecol Surv. 1995; 50(4).
Barnabei VM, Miller DS, Bauer KD, Murad TM, Rademaker AW, Lurain JR. Flow cytometric evaluation of epithelial ovarian cancer. Am J Obstet Gynecol. 1990; 162(6).
Barnabei VM, Sakamoto K, Seeley JK, Purtilo DT. Chromosomal breakage and sister chromatid exchange in peripheral blood lymphocytes and lymphoblastoid cell lines in the X-linked lymphoproliferative syndrome. Cancer Genet Cytogenet. 1982; 6(4).
Purtilo DT, Sakamoto K, Barnabei V, Seeley J, Bechtold T, Rogers G, Yetz J, Harada S, Barnabei VM. Epstein-Barr virus-induced diseases in boys with the X-linked lymphoproliferative syndrome (XLP): update on studies of the registry. Am J Med. 1982; 73(1).
Malik S, Barnabei VM. Cancer in Women. 2017.
Johnson JR, Barnabei VM. Preconception Counseling and Prenatal Diagnosis. 2017.
Kelly TE, Wachtel SS, Cahill L, Barnabei VM, Willson-Suddath K, Wyandt HE. X;Y translocation in a female with streak gonads, H-Y- phenotype, and some features of Turner‘s syndrome. Cytogenet Cell Genet. 1984; 38(2).
Barnabei VM, Wilson TA, Johanson AJ, Wyandt HE, Kelly T. Isodicentric X chromosome in a girl with gonadal dysgenesis. South Med J. 1983; 76(2).
Barnabei VM, Wyandt HE, Kelly TE. A possible exception to the critical region hypothesis. Am J Hum Genet. 1981; 33(1).